Literature DB >> 24083693

Hepatitis B virus gene mutations and hepatocarcinogenesis.

Tao Liang1, En-Qiang Chen, Hong Tang.   

Abstract

Chronic hepatitis B virus (HBV) infection has long been the most common cause of hepatocellular carcinoma (HCC). However, some aspects of the pathogenesis of HBV infection and genesis of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) are still inconclusive. An increasing number of published studies indicate that hepatitis B virus mutations are associated with risk of HCC. These variations include, in particular, mutations in ORF S,C,X gene regions. This mini-review summarizes results of clinical studies and molecular mechanisms on the possible relations of HBV mutations with the development of hepatocellular carcinoma.

Entities:  

Mesh:

Year:  2013        PMID: 24083693     DOI: 10.7314/apjcp.2013.14.8.4509

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  9 in total

1.  miRNA-708 functions as a tumour suppressor in hepatocellular carcinoma by targeting SMAD3.

Authors:  Qi Li; Sheng Li; Yaolu Wu; Feng Gao
Journal:  Oncol Lett       Date:  2017-06-20       Impact factor: 2.967

Review 2.  Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma.

Authors:  Caecilia H C Sukowati; Korri E El-Khobar; Susan I Ie; Beatrice Anfuso; David H Muljono; Claudio Tiribelli
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

3.  MicroRNA-337 regulates the PI3K/AKT and Wnt/β-catenin signaling pathways to inhibit hepatocellular carcinoma progression by targeting high-mobility group AT-hook 2.

Authors:  Hongzhang Cui; Ruijin Song; Ju Wu; Wei Wang; Xi Chen; Jiajun Yin
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

4.  Association between underexpression of microrna-203 and clinicopathological significance in hepatocellular carcinoma tissues.

Authors:  Yongru Liu; Fanghui Ren; Minhua Rong; Yihuan Luo; Yiwu Dang; Gang Chen
Journal:  Cancer Cell Int       Date:  2015-06-18       Impact factor: 5.722

5.  Hepatitis B virus (HBV) receptors: Deficiency in tumor results in scant HBV infection and overexpression in peritumor leads to higher recurrence risk.

Authors:  Ying-Ying Jing; Wen-Ting Liu; Shi-Wei Guo; Fei Ye; Qing-Min Fan; Guo-Feng Yu; Dan-Dan Yu; Lu Gao; Kai Sun; Zhi-Peng Han; Rong Li; Yang Yang; Qiu-Dong Zhao; Meng-Chao Wu; Hong-Yang Wang; Li-Xin Wei
Journal:  Oncotarget       Date:  2015-12-15

6.  A prominent role of Hepatitis D Virus in liver cancers documented in Central Africa.

Authors:  Marie Atsama Amougou; Dominique Noah Noah; Paul Fewou Moundipa; Pascal Pineau; Richard Njouom
Journal:  BMC Infect Dis       Date:  2016-11-07       Impact factor: 3.090

7.  CCR5 Polymorphism as a Protective Factor for Hepatocellular Carcinoma in Hepatitis B Virus-Infected Iranian Patients

Authors:  Reza Abdolmohammadi; Saleh Shahbazi Azar; Ayyoob Khosravi; Majid Shahbazi
Journal:  Asian Pac J Cancer Prev       Date:  2016-10-01

Review 8.  Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations.

Authors:  I-Chin Wu; Wen-Chun Liu; Ting-Tsung Chang
Journal:  J Biomed Sci       Date:  2018-06-02       Impact factor: 8.410

9.  Down-Regulation of MiR-193a-3p Dictates Deterioration of HCC: A Clinical Real-Time qRT-PCR Study.

Authors:  Yongru Liu; Fanghui Ren; Yihuan Luo; Minhua Rong; Gang Chen; Yiwu Dang
Journal:  Med Sci Monit       Date:  2015-08-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.